Proentherapeutics
The startup develops biopharmaceutical drugs using protein engineering to enhance immune activation and target cancer cells, thereby reducing the side effects associated with traditional chemotherapy. This approach aims to improve recovery outcomes for cancer patients, enabling them to achieve better health and quality of life.
Traction –/10
Daejeon, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biopharmaceutical drugs using protein engineering to enhance immune activation and target cancer cells, thereby reducing the side effects associated with traditional chemotherapy. This approach aims to improve recovery outcomes for cancer patients, enabling them to achieve better health and quality of life.